| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5053f82a7cd17c60822674b657cfb89e |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 |
| filingDate |
2006-12-14^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-01-04^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c48c5121ccef33d9304e8e82f4cb98df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ad655c1c4699081708494ba10385c1 |
| publicationDate |
2011-01-04^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2349479-T3 |
| titleOfInvention |
PHARMACEUTICAL COMBINATION THAT INCLUDES NUCLEOTID AND NUCLEOSIDIC INHIBITORS OF THE REVERSE TRANSCRIPT (SUCH AS TENOFOVIR AND LAMIVUDINE) IN DIFFERENT PARTS OF THE DOSAGE UNIT. |
| abstract |
A pharmaceutical formulation in a single unit dosage form, in which the dosage form comprises: (a) a reverse transcriptase nucleoside inhibitor, and (b) a reverse transcriptase nucleotide inhibitor the formulation being in the form of a multi-stratified tablet or a coated central tablet and in which the nucleoside reverse transcriptase inhibitor is provided in a different region of the dosage form than the nucleotide reverse transcriptase inhibitor. |
| priorityDate |
2005-12-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |